Genomics,Multiomics

Dataset Information

0

UroCAD-NCT03998371

ABSTRACT: Chromosomal instability (CIN) refers to ongoing chromosome segregation errors throughout consecutive cell divisions. CIN is a hallmark of human cancer, and it is associated with poor prognosis, metastasis, and therapeutic resistance. Analyzing CIN of the DNA extracted from urothelial cells in urine samples seems a promising method for diagnosing, monitoring, and predicting the prognosis of bladder cancer patients. CIN can be assessed using experimental techniques such as bulk DNA sequencing, fluorescence in situ hybridization (FISH), or conventional karyotyping. However, these techniques are either time-consuming or non-specific. We here intend to study whether a new method named Ultrasensitive Chromosomal Aneuploidy Detection (UCAD), which is based on low-coverage whole-genome sequencing, can be used to analyze CIN thus help diagnosing and treating bladder cancer patients.

OTHER RELATED OMICS DATASETS IN: PAe004331PAe004320PAe004328PAe004336PAe000247PAe004338PAe004325PAe004323PAe004330PAe004329PAe004319PAe004337PAe004322PAe004327PAe004333PAe003810PAe004335PAe004334PAe004321PAe000240PAe004326PAe004324PAe004332

TISSUE(S): Urine

SUBMITTER: Ziliang,Qian 

PROVIDER: OEX009998 | NODE |

REPOSITORIES: NODE

Json Xml
altmetric image

Publications

Noninvasive Detection of Urothelial Carcinoma by Cost-effective Low-coverage Whole-genome Sequencing from Urine-Exfoliated Cell DNA.

Zeng Shuxiong S   Ying Yidie Y   Xing Naidong N   Wang Baiyun B   Qian Ziliang Z   Zhou Zunlin Z   Zhang Zhensheng Z   Xu Weidong W   Wang Huiqing H   Dai Lihe L   Gao Li L   Zhou Tie T   Ji Jiatao J   Xu Chuanliang C  

Clinical cancer research : an official journal of the American Association for Cancer Research 20201009 21

<h4>Purpose</h4>Urothelial carcinoma is a malignant cancer with frequent chromosomal aberrations. Here, we investigated the application of a cost-effective, low-coverage whole-genome sequencing technology in detecting all chromosomal aberrations.<h4>Experimental design</h4>Patients with urothelial carcinomas and nontumor controls were prospectively recruited in clinical trial NCT03998371. Urine-exfoliated cell DNA was analyzed by Illumina HiSeq XTen, followed by genotyping with a customized bioi  ...[more]

Similar Datasets

Unknown Optimizing prognosis-related key miRNA-target interactions responsible for cancer metastasis.
1000-01-01 | S-EPMC5752539 | BioStudies
Unknown Metabolic Reprogramming in Triple-Negative Breast Cancer.
2020-01-01 | S-EPMC7136496 | BioStudies
Unknown Expression profile analysis identifies IER3 to predict overall survival and promote lymph node metastasis in tongue cancer.
2019-01-01 | S-EPMC6873470 | BioStudies
Unknown
2020-04-08 | S-SCDT-EMM-2018-09266 | BioStudies
Unknown Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.
2019-01-01 | S-EPMC6685079 | BioStudies
Unknown Tamoxifen enhances stemness and promotes metastasis of ER?36+ breast cancer by upregulating ALDH1A1 in cancer cells.
2018-01-01 | S-EPMC5835774 | BioStudies
Unknown Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming.
1000-01-01 | S-EPMC6276097 | BioStudies
Unknown Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells.
1000-01-01 | S-EPMC5503609 | BioStudies
Unknown High expression of ID1 facilitates metastasis in human osteosarcoma by regulating the sensitivity of anoikis via PI3K/AKT depended suppression of the intrinsic apoptotic signaling pathway.
2019-01-01 | S-EPMC6511763 | BioStudies
Unknown AXL receptor tyrosine kinase as a therapeutic target in NSCLC.
2015-01-01 | S-EPMC5217513 | BioStudies